Evidence map›Paper›PMID 35190419›Full record

ArticleBMJ open2022

Missed opportunities in hypertension risk factors screening in Indonesia: a mixed-methods evaluation of integrated health post (POSBINDU) implementation.

Vitri Widyaningsih, Ratih Puspita Febrinasari, Eti Poncorini Pamungkasari, Yusuf Ari Mashuri, Sumardiyono Sumardiyono, Balgis Balgis, Jaap Koot, Jeanet Landsman-Dijkstra, Ari Probandari, Scaling Up Non-Communicable Disease Intervention in South East Asia (SUNISEA) Project

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Beyond medication: factors contributing to uncontrolled hypertension from the 2023 Indonesian health survey.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Vitri WidyaningsihPublic Health, Universitas Sebelas Maret, Surakarta, Indonesia.ORCID 0000-0003-0116-7120
Ratih Puspita FebrinasariPharmacology, Universitas Sebelas Maret, Surakarta, Indonesia.
Eti Poncorini PamungkasariPublic Health, Universitas Sebelas Maret, Surakarta, Indonesia.
Yusuf Ari MashuriParasitology, Universitas Sebelas Maret, Surakarta, Indonesia.
Sumardiyono SumardiyonoPublic Health, Universitas Sebelas Maret, Surakarta, Indonesia.
Balgis BalgisPublic Health, Universitas Sebelas Maret, Surakarta, Indonesia.
Jaap KootDepartment of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.
Jeanet Landsman-DijkstraDepartment of Health Sciences, University Medical Centre Groningen, Groningen, The Netherlands.
Ari ProbandariPublic Health, Universitas Sebelas Maret, Surakarta, Indonesia ari.probandari@staff.uns.ac.id.ORCID 0000-0003-3171-5271
Scaling Up Non-Communicable Disease Intervention in South East Asia (SUNISEA) Project
Sebelas Maret University · IDUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the implementation and contextual barriers of POSBINDU, a community-based activity focusing on screening of non-communicable diseases (NCDs), mainly hypertension and diabetes, in Indonesia.

designThis was a concurrent mixed-methods study, with a cross-sectional analysis of secondary data and focus group discussions (FGDs) on stakeholder of POSBINDU.

settingThe study was conducted in seven districts in three provinces in Indonesia, with approximately 50% of the primary healthcare (PHC) were selected as areas for data collection (n PHC=100).

participantsFrom 475 POSBINDU sites, we collected secondary data from 54 224 participants. For the qualitative approach, 21 FGDs and 2 in-depth interviews were held among a total of 223 informants. PRIMARY OUTCOMES AND MEASURES: Proportion of POSBINDU visitors getting the hypertension screening and risk factors' assessment, and barriers of POSBINDU implementation.

resultsOut of the 114 581 POSBINDU visits by 54 224 participants, most (80%) were women and adults over 50 years old (50%) showing a suboptimal coverage of men and younger adults. Approximately 95.1% of visitors got their blood pressure measured during their first visit; 35.3% of whom had elevated blood pressure. Less than 25% of the visitors reported to be interviewed for NCDs risk factors during their first visit, less than 80% had anthropometric measurements and less than 15% had blood cholesterol examinations. We revealed lack of resources and limited time to perform the complexities of activities and reporting as main barrier for effective hypertension screening in Indonesia.

conclusionsThis study showed missed opportunities in hypertension risk factors screening in Indonesia. The barriers include a lack of access and implementation barriers (capability, resources and protocols).

Indexed as

HypertensionAdultBlood PressureCross-Sectional StudiesFemaleHumansIndonesiaMaleMiddle AgedRisk Factorshypertensioninternational health servicespublic healthquality in health care

Identifiers

PMID35190419
PMCPMC8862503
OpenAlexW4213062597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.